Flexible DCI Intubation Fiberscope, Part: 11301BND1, with Instruction Manual: Z18445US - Product ...

FDA Device Recall #Z-2894-2020 — Class II — July 27, 2020

Recall Summary

Recall Number Z-2894-2020
Classification Class II — Moderate risk
Date Initiated July 27, 2020
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Karl Storz Endoscopy
Location El Segundo, CA
Product Type Devices
Quantity 463

Product Description

Flexible DCI Intubation Fiberscope, Part: 11301BND1, with Instruction Manual: Z18445US - Product Usage: are intended to be used for examination and visualization of a patient s upper airway and for aiding placement of an endotracheal tube.

Reason for Recall

Updated sterilization instructions are being provided to ensure 1) a specific sterilization tray is not used, and 2) ethylene oxide sterilization is never used on certain reusable flexible intubation endoscopes with total lumen lengths greater than 850mm. Incompletely sterilized endoscopes might introduce infectious agents into patient airways, resulting in infection.

Distribution Pattern

Worldwide distribution - U.S. Nationwide distribution including in the states of CA, NY, PA, AZ, OH, NJ, FL, NC, IL, SC, MA, IA, ND, WI, UT, AR, GA, WA, KY, CO, TX, TN, AL, LA, NE, WV, MO, MN, VA, MT, CT, MI, IN, NM, NV, ME, VT, NH, WY, DC, DE, OR, OK, MD, ID, AK, MS, KS, HI, RI, SD and the country of Canada.

Lot / Code Information

Instruction Manual Version: 08/2018

Other Recalls from Karl Storz Endoscopy

Recall # Classification Product Date
Z-1062-2025 Class II KARL STORZ - ENDOSKOPE, REF: 27001K, Ureterosco... Dec 19, 2024
Z-1052-2025 Class II KARL STORZ - ENDOSKOPE, REF: 27030KA, Cysto-Ure... Dec 19, 2024
Z-1051-2025 Class II KARL STORZ - ENDOSKOPE, REF: 27003L, MICHEL Ure... Dec 19, 2024
Z-1055-2025 Class II KARL STORZ - ENDOSKOPE, REF: 27010L, Uretero-Re... Dec 19, 2024
Z-1057-2025 Class II KARL STORZ - ENDOSKOPE, REF: 27001L, Uretero-Re... Dec 19, 2024

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.